NO890661L - Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav. - Google Patents

Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav.

Info

Publication number
NO890661L
NO890661L NO89890661A NO890661A NO890661L NO 890661 L NO890661 L NO 890661L NO 89890661 A NO89890661 A NO 89890661A NO 890661 A NO890661 A NO 890661A NO 890661 L NO890661 L NO 890661L
Authority
NO
Norway
Prior art keywords
antihypercolesteroltetrazole
intermediates
compounds
preparation
antihypercolesteroltetrazole compounds
Prior art date
Application number
NO89890661A
Other languages
English (en)
Other versions
NO172439B (no
NO172439C (no
NO890661D0 (no
Inventor
William T Han
John J Wright
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO890661D0 publication Critical patent/NO890661D0/no
Publication of NO890661L publication Critical patent/NO890661L/no
Priority to NO922392A priority Critical patent/NO175636C/no
Priority to NO923358A priority patent/NO174850C/no
Publication of NO172439B publication Critical patent/NO172439B/no
Publication of NO172439C publication Critical patent/NO172439C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
NO890661A 1988-02-18 1989-02-16 Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten NO172439C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO922392A NO175636C (no) 1988-02-18 1992-06-18 6-formyl-1,3-dioksan-4-eddiksyreforbindelse, fremgangsmåte til fremstilling derav samt mellomprodukt til anvendelse ved fremgangsmåten
NO923358A NO174850C (no) 1988-02-18 1992-08-27 6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/156,865 US4824959A (en) 1988-02-18 1988-02-18 Intermediates for antihypercholesterolemic tetrazole compounds

Publications (4)

Publication Number Publication Date
NO890661D0 NO890661D0 (no) 1989-02-16
NO890661L true NO890661L (no) 1989-08-21
NO172439B NO172439B (no) 1993-04-13
NO172439C NO172439C (no) 1993-07-21

Family

ID=22561419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890661A NO172439C (no) 1988-02-18 1989-02-16 Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten

Country Status (32)

Country Link
US (1) US4824959A (no)
JP (2) JP2871707B2 (no)
KR (1) KR970002233B1 (no)
CN (1) CN1025619C (no)
AT (1) AT401057B (no)
AU (1) AU621586B2 (no)
BE (1) BE1002136A5 (no)
CA (1) CA1340430C (no)
CH (1) CH680792A5 (no)
CY (1) CY1874A (no)
DD (4) DD285603A5 (no)
DE (1) DE3904899A1 (no)
DK (1) DK75289A (no)
EG (1) EG19217A (no)
ES (1) ES2017810A6 (no)
FI (1) FI890725A (no)
FR (1) FR2630112B1 (no)
GB (1) GB2216121B (no)
GR (1) GR1000664B (no)
HK (3) HK129295A (no)
HU (2) HU209905B (no)
IE (1) IE65090B1 (no)
IT (1) IT1230750B (no)
LU (1) LU87456A1 (no)
MY (1) MY106279A (no)
NL (1) NL8900397A (no)
NO (1) NO172439C (no)
NZ (1) NZ227935A (no)
PT (1) PT89748B (no)
SE (2) SE503179C2 (no)
YU (1) YU34189A (no)
ZA (1) ZA891239B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244706B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole intermediates
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
DE4128345C1 (en) * 1991-08-27 1993-06-09 Hoechst Ag, 6230 Frankfurt, De 3R,5S 3,5,6-tri:hydroxy-hexanoic acid isopropylidene ketal derivs. prepn. - from 7-benzyl:oxy 4,6-di:hydroxy:heptene by multistage process
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE10147030A1 (de) * 2001-09-04 2003-03-27 Forschungszentrum Juelich Gmbh Verfahren zur Trennung diastereomerer 1,3-Diol-Acetale
EP1746988A1 (en) * 2004-05-11 2007-01-31 Darley Pharmaceuticals Ltd. Spiroderivatives for the treatment of hypertension
US20050272808A1 (en) * 2004-05-11 2005-12-08 Nadav Zamir Compositions and methods for the treatment of hypertension
CN104303915B (zh) * 2014-08-25 2016-05-25 李世峰 一种机插水稻水浮式育秧技术

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225085A (ja) * 1982-06-24 1983-12-27 Nippon Kayaku Co Ltd アセタ−ルグリコ−ルジアクリレ−トおよびその製造法
US4808621A (en) * 1986-07-07 1989-02-28 Warner-Lambert Company Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4837205A (en) * 1986-09-02 1989-06-06 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4751229A (en) * 1987-07-09 1988-06-14 Warner-Lambert Company Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles
DE3807929A1 (de) * 1988-03-10 1989-09-28 Basf Ag Verfahren zur herstellung von reliefformen

Also Published As

Publication number Publication date
DK75289D0 (da) 1989-02-17
HU204045B (en) 1991-11-28
EG19217A (en) 1995-09-30
FI890725A0 (fi) 1989-02-15
AT401057B (de) 1996-06-25
ZA891239B (en) 1991-12-24
FI890725A (fi) 1989-08-19
NL8900397A (nl) 1989-09-18
DD285600A5 (de) 1990-12-19
FR2630112B1 (fr) 1994-07-29
AU621586B2 (en) 1992-03-19
CN1036013A (zh) 1989-10-04
KR970002233B1 (ko) 1997-02-26
BE1002136A5 (fr) 1990-07-24
SE503179C2 (sv) 1996-04-15
KR890012992A (ko) 1989-09-20
MY106279A (en) 1995-04-29
PT89748A (pt) 1989-10-04
LU87456A1 (fr) 1989-09-20
NO172439B (no) 1993-04-13
CA1340430C (en) 1999-03-09
YU34189A (en) 1991-02-28
ATA36189A (de) 1995-10-15
PT89748B (pt) 1994-05-31
JPH115791A (ja) 1999-01-12
IE65090B1 (en) 1995-10-04
HUT50809A (en) 1990-03-28
CY1874A (en) 1996-04-05
NO172439C (no) 1993-07-21
ES2017810A6 (es) 1991-03-01
DD285603A5 (de) 1990-12-19
FR2630112A1 (fr) 1989-10-20
DE3904899A1 (de) 1989-08-31
US4824959A (en) 1989-04-25
JPH01249771A (ja) 1989-10-05
SE8900565L (sv) 1989-08-19
IT1230750B (it) 1991-10-29
AU3007589A (en) 1989-08-24
SE9300595A0 (sv) 1993-02-23
GB2216121B (en) 1992-07-15
DK75289A (da) 1989-08-19
GR1000664B (el) 1992-09-25
GB8903604D0 (en) 1989-04-05
DD285602A5 (de) 1990-12-19
GB2216121A (en) 1989-10-04
JP2922887B2 (ja) 1999-07-26
DD283618A5 (de) 1990-10-17
JP2871707B2 (ja) 1999-03-17
HU209905B (en) 1994-11-28
HK129295A (en) 1995-08-24
CH680792A5 (no) 1992-11-13
NO890661D0 (no) 1989-02-16
HK47596A (en) 1996-03-29
HK129395A (en) 1995-08-24
CN1025619C (zh) 1994-08-10
IT8919474A0 (it) 1989-02-17
IE890523L (en) 1989-08-18
SE8900565D0 (sv) 1989-02-17
HUT50167A (en) 1989-12-28
NZ227935A (en) 1990-07-26
SE9300595D0 (sv) 1993-02-23

Similar Documents

Publication Publication Date Title
NO880812L (no) Fremstilling av zeolitt l.
NO167138C (no) Keramisk formdel og anvendelse av denne.
NO165494C (no) Aminosalter av lignosulfonater og anvendelse derav.
NO890661L (no) Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav.
NO884566L (no) Anvendelse av fluorderivater og kontrastpreparat for diagnostisering av ondartede neoplasmer.
NO882462D0 (no) Fremstilling og bruk av fenolderivater.
FI853938A0 (fi) Anordning foer profilmaetning av raelshjul.
NO890061D0 (no) Fremstilling og anvendelse av gallosilikataromatiseringskatalysator.
ES2017606A4 (es) Preparacion de n - acil - aminometilfosfonatos
NO893143D0 (no) Fremstilling av klordioksyd.
NO905104D0 (no) Proevetaking av boreslam.
NO872140D0 (no) Polyetere, fremstilling og anvendelse av slike.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO882336L (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
NO880802D0 (no) Mellomprodukter og fremgangsmaater til fremstilling av antihyperkolesterolemiske tetrazolforbindelser.
NO892470L (no) Fremstilling av laktolderivater.
NO173389C (no) Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivater
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
NO861083L (no) Analogifremgangsmaate og fremstilling av imidazoisokinoliner og imidazo-tienopyridin-forbindelser.
NO912279D0 (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO923358L (no) Fremgangsmaate for fremstilling av antihyperkolesterolemiske tetrazolforbindelser og mellomprodukter derav
KR900004740U (ko) 일부인
NO901421D0 (no) Intranasal administrering av fysostigmin og arecolin.
FI883463A0 (fi) Anordning foer undervattensarbete.
NO911673D0 (no) Filament - hemagglutinin av b. pertussis.

Legal Events

Date Code Title Description
MK1K Patent expired